Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Labcyte Inc.

www.labcyte.com

Latest From Corthera Inc.

Second CHMP knock back for Novartis's serelaxin

The EU's CHMP has again refused to recommend approval of Novartis's acute heart failure therapy RLX030 (serelaxin), just weeks after the FDA rejected the BLA in the US (scripintelligence.com, 16 May 2014). The EU committee originally said no in January and has now confirmed its stance after Novartis requested a re-examination the following month.

Cardiovascular Regulation

Novartis Likely Stuck Waiting For Second Phase III For Serelaxin Approval

FDA recommends against approval of Novartis’ heart failure drug serelaxin in run up to advisory panel, signaling company may need second Phase III study just beginning to get drug okayed.

BioPharmaceutical North America

Too soon for Novartis's serelaxin, says CHMP

The EU's CHMP has knocked back Novartis's application for conditional approval of its acute heart failure treatment serelaxin (RLX030), ahead of its US FDA panel meeting in a few weeks.

Cardiovascular Regulation

Domain and Adynxx CEO Orr engineer another venture exit as Cubist options pain drug

If the recently initiated Phase II trial for Adynxx's post-surgical pain drug AYX1 is successful, the San Francisco-based company's CEO Rick Orr and Domain Associates partner Dennis Podlesak will complete their fifth successful exit for venture capital investors in an entrepreneurial biotechnology firm.

Cardiovascular Orthopedics
See All

Company Information

  • Industry
  • Medical Devices
  • Therapeutic Areas
  • Alias(es)
  • Picoliter Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Labcyte Inc.
  • Senior Management
  • Elaine J Heron, PhD, Chmn. & CEO
    Ted Williams, VP, Bus. Dev.
    Michael F Miller, VP, R&D
    Chris Grimley, VP, Mktg.
  • Contact Info
  • Labcyte Inc.
    Phone: (408) 747-2000
    1190 Borregas Ave.
    Sunnyvale, CA 94089
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register